IRIS Accounts Production v23.2.0.158 12865756 director 1.2.22 31.1.23 31.1.23 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure128657562022-01-31128657562023-01-31128657562022-02-012023-01-31128657562020-09-07128657562020-09-082022-01-31128657562022-01-3112865756ns16:EnglandWales2022-02-012023-01-3112865756ns15:PoundSterling2022-02-012023-01-3112865756ns11:Director12022-02-012023-01-3112865756ns11:PrivateLimitedCompanyLtd2022-02-012023-01-3112865756ns11:SmallEntities2022-02-012023-01-3112865756ns11:AuditExempt-NoAccountantsReport2022-02-012023-01-3112865756ns11:SmallCompaniesRegimeForDirectorsReport2022-02-012023-01-3112865756ns11:SmallCompaniesRegimeForAccounts2022-02-012023-01-3112865756ns11:FullAccounts2022-02-012023-01-3112865756ns11:RegisteredOffice2022-02-012023-01-3112865756ns6:CurrentFinancialInstruments2023-01-3112865756ns6:CurrentFinancialInstruments2022-01-3112865756ns6:ShareCapital2023-01-3112865756ns6:ShareCapital2022-01-3112865756ns6:RetainedEarningsAccumulatedLosses2023-01-3112865756ns6:RetainedEarningsAccumulatedLosses2022-01-3112865756ns6:WithinOneYearns6:CurrentFinancialInstruments2023-01-3112865756ns6:WithinOneYearns6:CurrentFinancialInstruments2022-01-31
REGISTERED NUMBER: 12865756 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 JANUARY 2023

FOR

MEDIVOICE RECRUIT LTD

MEDIVOICE RECRUIT LTD (REGISTERED NUMBER: 12865756)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JANUARY 2023










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


MEDIVOICE RECRUIT LTD

COMPANY INFORMATION
FOR THE YEAR ENDED 31 JANUARY 2023







DIRECTOR: Mr Suman Datta





REGISTERED OFFICE: Unit 1 Unit 1 Orion Avenue
Great Blakenham
Ipswich
IP6 0LW





REGISTERED NUMBER: 12865756 (England and Wales)






MEDIVOICE RECRUIT LTD (REGISTERED NUMBER: 12865756)

BALANCE SHEET
31 JANUARY 2023

31.1.23 31.1.22
Notes £    £   
CURRENT ASSETS
Stocks 18,974 -
Debtors 4 141,623 100
Cash at bank 33,288 -
193,885 100
CREDITORS
Amounts falling due within one year 5 53,983 -
NET CURRENT ASSETS 139,902 100
TOTAL ASSETS LESS CURRENT
LIABILITIES

139,902

100

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings 139,802 -
139,902 100

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 January 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 January 2023 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 3 October 2023 and were signed by:





Mr Suman Datta - Director


MEDIVOICE RECRUIT LTD (REGISTERED NUMBER: 12865756)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JANUARY 2023


1. STATUTORY INFORMATION

Medivoice Recruit Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Stocks
Work in progress is valued at the lower of cost and net realisable value.

Cost is calculated using the first-in, first-out method and includes all purchase, transport, and handling costs in bringing stocks to their present location and condition.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2022 - 1 ) .

4. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.1.23 31.1.22
£    £   
Trade debtors 139,306 -
Other debtors 2,317 100
141,623 100

5. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.1.23 31.1.22
£    £   
Trade creditors 1,103 -
Amounts owed to group undertakings 14,256 -
Taxation and social security 35,149 -
Other creditors 3,475 -
53,983 -

MEDIVOICE RECRUIT LTD (REGISTERED NUMBER: 12865756)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 JANUARY 2023


6. RELATED PARTY DISCLOSURES

100% of the share capital of the company is owned by Evella Holdings Limited. On 3 March 2023 100% of the share capital of Evella Holdings was purchased by Velox Operations LLC.

The company is related to Creative Medical Research Limited and Healthcare Fieldwork Limited, both companies registered in England and Wales, by virtue of common control.

At the year end the company owed £14,256.85 (2022: £Nil) to Creative Medical Research Limited.

7. ULTIMATE CONTROLLING PARTY

The controlling party is Mr Suman Datta.